1. | Mitenko P, Ogivie R. Rational intravenous doses of theophylline. N Engl J Med 1973;289:600-603. |
2. | Lesko LJ. Dose-dependent elimination kinetics of theophylline. Clin Pharmacokinetics 1979;4:449-459. |
3. | Hendeles L, Weinberger M. Theophylline: a state of the art review. Pharmacotherapy 1983: 3:2-44. |
4. | Mungall DE, et al. Individualizing theophylline therapy: the impact of a clinical pharmacotherapeutics on patient outcome: Ther Drug Monit 1983; 5:95-101. |
5. | Iafrate RP, et al. Computer simulated conversion from intravenous to sustained release oral theophylline. DICP 1982;16:19-25. |
6. | Stein GE, et al. Conversion from intravenous to oral dosing using sustained-release theophylline tablets. DICP 1982;16:772-774. |
7. | Coleman RW, Hedberg RL. Comparison of three methods for estimating theophylline pharmacokinetics. Clin Pharm 1983;2:148-52. |
8. | Hatton RC, et al. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results. Clin Pharm 1983; 2:347-352. |
9. | Dunn G, Rybak MJ. Nonlinear theophylline kinetics (letter). DICP 1984;18:155. |
10. | Johnson MH, Burkle WS. Evaluation of Chiou method for determining theophylline dosages. Clin Pharm 1984; 3:174-8. |
11. | Hendeles L, et al. Update on pharmacodynamics and pharmacokinetics of theophylline. Chest 1985; 88:10S-111S. |
12. | Ellis E, Hendeles L. "Theophylline", in Taylor WJ, Caviness MH (eds): A Textbook for the Clinical Application of Therapeutic Drug Monitoring. Irving, Texas. Abbott Laboratories, 1986; pp. 185-201. |
13. | Hendeles L, et al. "Theophylline" In: Applied Pharmacokinetics, Second Edition. Spokane, WA: Applied Therapeutics, Inc., 1986. pp 1105-1188. |
14. | Leoni J, Carasiti ME. Practical guidelines for intravenous theophylline dosing. Res Staff Physician 1987;Oct 153-155. |
15. | Donahue T, et al. Pharmacist-based IV theophylline therapy. Hosp Pharm 1989;24:440-448,460. |
See also:
Introduction
Monitoring parameters
Precautions
Pharmacokinetic formulas
|